TABLE 1.
Research article | Pain type | Resolvin | TRP channel | Results | Potential mechanisms |
Bang et al., 2010 | Inflammatory | RvD1 | TRPA1 TRPV3 TRPV4 | ↓activities the three TRP channels at nanomolar and micromolar levels **No effects of FPR2/ALX agonists on the three TRP channels | |
Xu et al., 2010 | Inflammatory | RvE1 RvD1 | TRPV1 | ↓EPSC frequency increases induced by capsaicin, with the ChemR23 agonist ↓EPSC frequency increase by TNF-α and NMDAR hyperactivity with RvE1 | RvE1 modulates the ERK signaling pathway to abolish TNF-α-evoked NMDA receptor hyperactivity in dorsal horn neurons |
Park et al., 2011b | Inflammatory | RvD1 RvD2 RvE1 | TRPV1 TRPA1 | ↓sEPSC increases both TRP channels with RvD2 at extremely low doses (compared to RvD1/E1) **No effect of RvD2 when GPCRs are blocked | Distinct mechanisms of the resolvins in regulating TRP channels RvD2 involves specific GPCRs |
Luo et al., 2019 | Neuropathic (CIPN induced) Inflammatory (**RvD5 only) | RvD1 RvD2 RvD5 | TRPA1 TRPV1 (**Knock-out mice) | ↓ neuropathic pain behaviors, with RvD1/D2 ** only in male mice, with RvD5 ↓inflammatory pain behaviors in male mice only with RvD5 | Sex dimorphism of RvD5’s analgesia in both pain models |
CFA, complete Freund’s adjuvant; CIPN, chemotherapy-induced peripheral neuropathy; EPSC, excitatory postsynaptic current; ERK, extracellular signal-regulated kinase; FPR2/ALX, formyl peptide receptor 2; GPCRs, G-protein coupled receptors; NMDAR, N-methyl-D-aspartic acid receptor; RvE, resolvin E; RvD, resolvin D; TNF-α, tumor necrosis factor-α; TRP, transient receptor potential. ** Indicates supplementary information.